My bookmarksSign up free
Source

Commission Implementing Decision (EU) 2025/439 of 28 February 2025 establishing a watch list of substances for Union-wide monitoring in the field of water policy pursuant to Directive 2008/105/EC of the European Parliament and of the Council (notified under document C(2025) 1244)

Commission Implementing Decision (EU) 2025/439 of 28 February 2025 establishing a watch list of substances for Union-wide monitoring in the field of water policy pursuant to Directive 2008/105/EC of the European Parliament and of the Council (notified under document C(2025) 1244)

Implementing Decision (EU) 2025/439 · Decision · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The watch list of substances for Union-wide monitoring referred to in Article 8b of Directive 2008/105/EC is set out in the Annex to this Decision.

Supplementary provisions

Watch list of substances for Union-wide monitoring as set out in Article 8b of Directive 2008/105/EC

ANNEXSupplementary provisions

Open ↗

ANNEX Watch list of substances for Union-wide monitoring as set out in Article 8b of Directive 2008/105/EC Name of substance/group of substances Chemical Abstracts Service (CAS) number European Community (EC) number  ( 1 ) Indicative analytical method  ( 2 ) ,  ( 3 ) Maximum acceptable method quantification limit (ng/l) Fipronil 120068-37-3 424-610-5 SPE-HPLC-MS/MS 0,77 Clindamycin 18323-44-9 242-209-1 SPE-LC-MS/MS 44 Ofloxacin 82419-36-1 680-263-1 SPE-UHPLC-MS/MS 26 Metformin and Guanylurea  ( 4 ) 657-24-9 141-83-3 211-517-8 205-504-6 SPE-LC-MS/MS 156 000 100 000 Sunscreen agents  ( 5 ) Butyl methoxydibenzoyl-methane Octocrylene Benzophenone-3 Octisalate (2-ethylhexyl salicylate) 70356-09-1 6197-30-4 131-57-7 118-60-5 274-581-6 228-250-8 205-031-5 204-263-4 SPE-LC-ESI-MS/MS 3 000 266 670 168 N-1,3-Dimethylbutyl-N’-phenyl-p-phenylenediamine (6PPD) and 6PPD-quinone  ( 6 ) 793-24-8 2754428-18-5 212-344-0 893-269-6 SPE-LC-MS/MS 370 Abamectin  ( 7 ) Avermectin B1a and Avermectin B1b 71751-41-2 65195-55-3 65195-56-4 265-610-3 265-611-9 SPE-LC-MS/MS 1 Azole compounds  ( 8 ) Bromuconazole Climbazole Cyazofamid Difenoconazole Epoxiconazole Itraconazole Ketoconazole Mefentrifluconazole Propiconazole Triticonazole 116255-48-2 38083-17-9 120116-88-3 119446-68-3 133855-98-8 84625-61-6 65277-42-1 1417782-03-6 60207-90-1 131983-72-7 408-060-3 253-775-4 601-671-8 601-613-1 406-850-2 617-596-9 265-667-4 822-682-6 262-104-4 603-543-7 SPE-LC-MS/MS 15 110 130 360 180 8 50 1 600 1 000 1 000 Etoxazole 153233-91-1 604-891-2 SPE-GC-MS/MS 0,4 Fluoxetine 54910-89-3 611-209-7 SPE-LC-QTOF-HRMS 12 Propranolol 525-66-6 208-378-0 SPE-LC-MS/MS 20 Oxytetracycline and Tetracycline  ( 9 ) 79-57-2 60-54-8 201-212-8 200-481-9 SPE-LC-MS/MS 500 90 ( 1 )   Not available for all substances ( 2 )   All substances shall be monitored in whole water samples. ( 3 )   Extraction methods: SPE – solid-phase extraction Analytical methods: HPLC-MS/MS– High-performance liquid chromatography (tandem) triple quadrupole mass spectrometry LC-MS/MS – Liquid chromatography (tandem) triple quadrupole mass spectrometry LC-ESI-MS/MS – Liquid chromatography (tandem) triple quadrupole mass spectrometry with positive electrospray ionisation LC-QTOF-HRMS – Liquid chromatography quadrupole time-of-flight high-resolution mass spectrometry UHPLC-MS/MS – Ultra-high-performance liquid chromatography (tandem) triple quadrupole mass spectrometry ( 4 )   Metformin and guanylurea shall be analysed together in the same samples but reported as individual concentrations. ( 5 )   The sunscreen agents shall be analysed together in the same samples but reported as individual concentrations. ( 6 )   6PPD and 6PPD-quinone shall be analysed together in the same samples but reported as individual concentrations ( 7 )   The two major components of abamectin (B1a and B1b) shall be analysed together in the same samples and reported as a sum concentration. ( 8 )   The azole compounds shall be analysed together in the same samples but reported as individual concentrations. ( 9 )   Oxytetracycline and tetracycline shall be analysed together in the same samples but reported as individual concentrations.

Other acts of the same type
Council Decision (CFSP) 2022/1972 of 17 October 2022 amending Decision (CFSP) 2022/339 on an assistance measure under the European Peace Facility to support the Ukrainian Armed ForcesCouncil Decision (EU) 2022/1976 of 17 October 2022 on the position to be adopted, on behalf of the Union, within the Trade Committee established by the Free Trade Agreement between the European Union and the Republic of Singapore, as regards the adoption of the rules of procedure of the Trade CommitteeCouncil Decision (EU) 2022/1977 of 17 October 2022 on the position to be taken on behalf of the European Union within the EU-Ukraine Association Committee in Trade configuration established by the Association Agreement between the European Union and the European Atomic Energy Community and their Member States, of the one part, and Ukraine, of the other part, as regards the update of Annex XV (Approximation of customs legislation) to that AgreementCouncil Decision (EU) 2022/1994 of 17 October 2022 on the position to be taken on behalf of the European Union within the Sub-Committee on Geographical Indications established by the Comprehensive and Enhanced Partnership Agreement between the European Union and the European Atomic Energy Community and their Member States, of the one part, and the Republic of Armenia, of the other part, as regards the adoption of its rules of procedureCouncil Decision (EU) 2022/1995 of 17 October 2022 appointing three representatives of Member States as members and alternate members of the Management Board of the European Food Safety AuthorityCouncil Decision (CFSP) 2022/1943 of 13 October 2022 amending Decision (CFSP) 2019/1720 concerning restrictive measures in view of the situation in NicaraguaCouncil Decision (CFSP) 2022/1944 of 13 October 2022 amending Decision (CFSP) 2018/1544 concerning restrictive measures against the proliferation and use of chemical weaponsCommission Implementing Decision (EU) 2022/1947 of 13 October 2022 amending Implementing Decision (EU) 2020/1550 by updating the multiannual programme of controls for the period 2021-2025 and establishing the programme of controls for 2023Commission Implementing Decision (EU) 2022/1948 of 13 October 2022 establishing the equivalence, for the purpose of facilitating the right of free movement within the Union, of COVID-19 certificates issued by the Federative Republic of Brazil to the certificates issued in accordance with Regulation (EU) 2021/953 of the European Parliament and of the Council (Text with EEA relevance)Commission Implementing Decision (EU) 2022/1949 of 13 October 2022 establishing the equivalence, for the purpose of facilitating the right of free movement within the Union, of COVID-19 certificates issued by New Zealand in respect of the Cook Islands, Niue and Tokelau to the certificates issued in accordance with Regulation (EU) 2021/953 of the European Parliament and of the Council (Text with EEA relevance)Council Decision (EU) 2022/1951 of 13 October 2022 appointing the Secretary-General of the Council of the European Union for the period from 1 November 2022 to 31 October 2027Council Decision (EU) 2022/1952 of 13 October 2022 on the position to be taken on behalf of the Union within the Special Committee on Geographical Indications and Trade in Wines and Spirits established by the Economic Partnership Agreement between the European Union and its Member States, of the one part, and the SADC EPA States, of the other part, as regards the adoption of the rules of procedure of the Special Committee

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next